Related Experiment Video
Updated: Aug 7, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
[Recent progress and perspectives in the management of patients with lung cancer]
Fabrice Barlesi1, Céline Gimenez, Michèle Pibarot
1Service d'oncologie respiratoire, Département des maladies respiratoires, Hôpital Sainte-Marguerite, 270, bd Sainte-Marguerite, BP 29, 13274 Marseille Cedex 09. fbarlesi@ap-hm.fr
Abstract:
Lung cancer is still actually a leading cause of death in industrial countries, while the major etiologic agent, the tobacco smoke, is clearly identified. Primary or secondary prevention's strategies are frequently unsuccessful. The main survival chance is an early diagnosis of the disease. Efforts in the lung cancer screening have to be continued. Therapeutic strategies improved but progress in terms of survey are disappointing. Hopes relies on new drugs development coming from fundamental research, for whom first clinical trials are ongoing.
Insights
Lung cancer remains a leading cause of death, with tobacco smoke as the primary cause. Early diagnosis through continued screening efforts offers the best survival chance, as current therapies show limited progress.
Area of Science:
- Oncology
- Public Health
- Epidemiology
Context:
- Lung cancer is a significant global health issue and a leading cause of mortality in industrialized nations.
- Tobacco smoke is the primary identified etiological agent responsible for lung cancer.
- Existing primary and secondary prevention strategies for lung cancer have demonstrated limited success.
Purpose:
- To emphasize the critical need for continued advancements in lung cancer screening methodologies.
- To highlight the limitations of current therapeutic strategies in improving patient survival rates.
- To underscore the potential of novel drug development stemming from fundamental research for future treatment.
Summary:
- Despite advancements, lung cancer survival rates remain disappointing, underscoring the need for improved early detection.
- Current therapeutic strategies have not significantly improved patient outcomes, necessitating new approaches.
- Ongoing clinical trials for new drugs derived from fundamental research offer future hope for lung cancer treatment.
Impact:
- Enhanced lung cancer screening programs can lead to earlier diagnosis and improved patient survival.
- Further investment in fundamental research is crucial for developing more effective lung cancer therapies.
- The development of novel therapeutic agents holds the potential to significantly alter the prognosis for lung cancer patients.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Asthma-IV: Nursing Management
First, in...
Cancer Survival Analysis
